154 related articles for article (PubMed ID: 19878416)
1. Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
Drees JC; Stone JA; Wu AH
J Forensic Sci; 2009 Nov; 54(6):1485-7. PubMed ID: 19878416
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
Chèze M; Deveaux M; Martin C; Lhermitte M; Pépin G
Forensic Sci Int; 2007 Aug; 170(2-3):100-4. PubMed ID: 17629643
[TBL] [Abstract][Full Text] [Related]
3. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of MDMA/MDA in both hair and urine in drug users.
Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H
Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177
[TBL] [Abstract][Full Text] [Related]
5. MDA-MDMA concentrations in urine specimens.
Kunsman GW; Levine B; Kuhlman JJ; Jones RL; Hughes RO; Fujiyama CI; Smith ML
J Anal Toxicol; 1996; 20(7):517-21. PubMed ID: 8934299
[TBL] [Abstract][Full Text] [Related]
6. Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens.
Liu RH; Liu HC; Lin DL
J Anal Toxicol; 2006 Oct; 30(8):545-50. PubMed ID: 17132249
[TBL] [Abstract][Full Text] [Related]
7. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP
Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A; Farrugia A; Raul JS; Kintz P
Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
[TBL] [Abstract][Full Text] [Related]
9. Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B).
Power JD; Kavanagh P; O'Brien J; Barry M; Twamley B; Talbot B; Dowling G; Brandt SD
Drug Test Anal; 2015 Jun; 7(6):512-8. PubMed ID: 25078895
[TBL] [Abstract][Full Text] [Related]
10. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
[TBL] [Abstract][Full Text] [Related]
12. Unexpected Serotonin Syndrome, Epileptic Seizures, and Cerebral Edema Following 2,5-dimethoxy-4-bromophenethylamine Ingestion.
Spoelder AS; Louwerens JKG; Krens SD; Jager N; LeCouffe NE; de Ruijter W; Brunt TM
J Forensic Sci; 2019 Nov; 64(6):1950-1952. PubMed ID: 31643086
[TBL] [Abstract][Full Text] [Related]
13. Fatality due to the use of a designer drug MDMA (Ecstasy).
Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
[TBL] [Abstract][Full Text] [Related]
14. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
15. Rapid and simple determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography-mass spectrometry using micro-pulverized extraction.
Kim JY; Shin SH; Lee JI; In MK
Forensic Sci Int; 2010 Mar; 196(1-3):43-50. PubMed ID: 20060242
[TBL] [Abstract][Full Text] [Related]
16. 3-MeO-PCP intoxication in two young men: First in vivo detection in Italy.
Bertol E; Pascali J; Palumbo D; Catalani V; Di Milia MG; Fioravanti A; Mari F; Vaiano F
Forensic Sci Int; 2017 May; 274():7-12. PubMed ID: 28057371
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.
Pasin D; Cawley A; Bidny S; Fu S
Drug Test Anal; 2017 Oct; 9(10):1620-1629. PubMed ID: 28133938
[TBL] [Abstract][Full Text] [Related]
18. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
19. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.
Kerrigan S; Mott A; Jatzlau B; Ortiz F; Perrella L; Martin S; Bryand K
J Forensic Sci; 2014 Jan; 59(1):175-83. PubMed ID: 24313279
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine as the most common concomitant substance used with pregabalin misuse.
Ovat DY; Aslan R; Kirli U; Akgür SA
J Pharm Biomed Anal; 2024 Apr; 241():115996. PubMed ID: 38330785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
